Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
EV/EBITDA Over TimeStrong
Percentile Rank86
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-0.73
↑ 96% vs avg
Percentile
P86
Within normal range
Streak
2 yr
Consecutive growthStrong
Average
-19.61
Historical baseline
PeriodValueYoY Change
2022-0.73+1.1%
2021-0.74+66.9%
2020-2.24-1.2%
2019-2.21+72.3%
2018-7.98+61.5%
2017-20.75-176.1%
2016-7.51+92.2%
2015-96.41-170.7%
2014-35.61-62.6%
2013-21.90-